Key result
Visceral adiposity index strongly tracks with higher HbA1c and leptin-to-adiponectin ratio in T2DM.
Why the study?
Does the visceral adiposity index (VAI) correlate more strongly with glycaemic and lipid abnormalities than BMI in adults with type 2 diabetes mellitus?
Population
90 adults diagnosed with type 2 diabetes mellitus, stratified into normal weight, overweight, and obese.
Design
Cross-sectional
Authors
Loading...
The visceral adiposity index (VAI) is a stronger predictor of glycaemic and lipid abnormalities than BMI in patients with type 2 diabetes mellitus, highlighting its utility in assessing metabolic risk.
Cross-Sectional (n=90)
Does the visceral adiposity index (VAI) correlate more strongly with glycaemic and lipid abnormalities than BMI in adults with type 2 diabetes mellitus?
Effect estimate: β = 0.52 for HbA1c; β = 0.71 for leptin-to-adiponectin ratio
p-value: p=< 0.001
The visceral adiposity index (VAI) is a stronger predictor of glycaemic and lipid abnormalities than BMI in patients with type 2 diabetes mellitus, highlighting its utility in assessing metabolic risk.
Shaheer et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus (T2DM) (n=90). Visceral adiposity index (VAI) vs. Body mass index (BMI) was evaluated on HbA1c levels and leptin-to-adiponectin ratio (β = 0.52 for HbA1c; β = 0.71 for leptin-to-adiponectin ratio, p=< 0.001). The visceral adiposity index was the strongest independent predictor of HbA1c levels (β = 0.52) and the leptin-to-adiponectin ratio (β = 0.71) in adults with type 2 diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: